CVS Group (LON:CVSG) Given "Outperform" Rating at Royal Bank Of Canada

Key Points

• CVS Group received an "outperform" rating from Royal Bank of Canada, with a price target of GBX 1,500, indicating a potential upside of 19.43% from its current price.
• Berenberg Bank reiterated a buy rating for CVS Group, setting a higher price target of GBX 2,000, while the stock has a consensus rating of Buy with a target of GBX 1,750.
• Insider buying activity includes a purchase of 1,000 shares by David Wilton at an average cost of GBX 1,248, reflecting insider confidence in the company’s prospects.

Royal Bank Of Canada restated their outperform rating on shares of CVS Group (LON:CVSG - Free Report) in a research note published on Friday morning, Marketbeat.com reports. The brokerage currently has a GBX 1,500 target price on the stock.

Separately, Berenberg Bank reissued a "buy" rating and issued a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday, July 24th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of GBX 1,750.

CVS Group Stock Down 3.3%

Shares of CVS Group stock traded down GBX 42 on Friday, hitting GBX 1,228. The company had a trading volume of 270,356 shares, compared to its average volume of 306,044. The stock has a market capitalization of £880.97 million, a price-to-earnings ratio of 32,315.79, a P/E/G ratio of 1.77 and a beta of 1.02. CVS Group has a 1 year low of GBX 791 and a 1 year high of GBX 1,342. The stock has a 50 day moving average of GBX 1,234.84 and a 200-day moving average of GBX 1,155.61. The company has a debt-to-equity ratio of 110.52, a quick ratio of 0.90 and a current ratio of 1.09.

Insider Buying and Selling at CVS Group

In other news, insider David Wilton acquired 1,000 shares of CVS Group stock in a transaction on Monday, June 2nd. The stock was acquired at an average cost of GBX 1,248 per share, with a total value of £12,480. Also, insider Richard Fairman acquired 1,644 shares of CVS Group stock in a transaction on Friday, July 11th. The shares were purchased at an average cost of GBX 1,216 per share, with a total value of £19,991.04. 1.37% of the stock is currently owned by corporate insiders.

CVS Group Company Profile

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.